If the expression level of HILPDA in human liver is sufficiently high, inactivation of HILPDA could in theory be a promising strategy to treat non-alcoholic fatty liver disease. The gene discussed is HILPDA; the disease is metabolic dysfunction-associated steatotic liver disease.